DJIA 16,041.12 26.74 0.17%
NASDAQ 4,325.69 56.93 1.33%
S&P 500 1,863.44 11.23 0.61%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

49.81 0.65 (1.32%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $49.80 1.30%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.51
Previous Close $49.16
Daily Range $49.50 - $50.41
52-Week Range $45.69 - $61.70
Market Cap $139.1B
P/E Ratio 13.69
Dividend (Yield) $1.84 (3.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 7,595,756
Average Daily Volume 12,920,895
Current FY EPS $3.57




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

3 Biotech Stocks to Buy in a Market Crash

Gilead Sciences, Celgene Corp, and Regeneron Pharmaceuticals are best-in-class in biotech.

Following Alpha: Franchise Partners - Q4 2015 Review

Notable ETF Inflow Detected - IVE, BAC, MRK, UTX

Dow Movers: DIS, V

Short Sellers Increase Bets in Major Pharma

ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet

Pfizer Gets Back to Growth

Guidance for 2016 suggests that a corner is turning for this industry Goliath.

Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck

Merck's Zepatier poses a new challenge to Gilead's best-selling drug, but maybe it's not as threatening as some think.

1 Chart That's Bringing Big Smiles to America's Largest Companies

You might be witnessing a sea of red, but the recent retracement in this index could be a very good thing for America's largest companies.

Bristol-Myers' Daklinza-Sovaldi Label Expanded by the FDA

See More MRK News...

MRK's Top Competitors

MRK $49.81 (1.32%)
Current stock: MRK
JNJ $101.95 (-0.02%)
Current stock: JNJ
NVS $73.16 (0.74%)
Current stock: NVS
RHHBY $31.36 (0.69%)
Current stock: RHHBY